CY2318B1 - Microparticles. - Google Patents

Microparticles.

Info

Publication number
CY2318B1
CY2318B1 CY0300017A CY0300017A CY2318B1 CY 2318 B1 CY2318 B1 CY 2318B1 CY 0300017 A CY0300017 A CY 0300017A CY 0300017 A CY0300017 A CY 0300017A CY 2318 B1 CY2318 B1 CY 2318B1
Authority
CY
Cyprus
Prior art keywords
microparticles
organic solvent
total weight
active agent
less
Prior art date
Application number
CY0300017A
Other languages
English (en)
Inventor
Michael E Rickey
J Michael Ramstack
Danny H Lewis
Jean Louis Mesens
Original Assignee
Alkermes Inc
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24582704&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2318(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alkermes Inc, Janssen Pharmaceutica Nv filed Critical Alkermes Inc
Publication of CY2318B1 publication Critical patent/CY2318B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CY0300017A 1996-05-07 2003-01-16 Microparticles. CY2318B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64391996A 1996-05-07 1996-05-07

Publications (1)

Publication Number Publication Date
CY2318B1 true CY2318B1 (en) 2003-11-14

Family

ID=24582704

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300017A CY2318B1 (en) 1996-05-07 2003-01-16 Microparticles.

Country Status (11)

Country Link
EP (1) EP1210942B1 (de)
AT (2) ATE357218T1 (de)
CY (1) CY2318B1 (de)
DE (2) DE69737515T2 (de)
DK (2) DK1210942T3 (de)
ES (2) ES2183172T3 (de)
HK (1) HK1047539B (de)
MY (1) MY118174A (de)
PT (2) PT1210942E (de)
SI (2) SI0904063T1 (de)
TR (1) TR199802258T2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
AU2002337692B2 (en) 2001-09-26 2007-09-13 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2008143992A2 (en) 2007-05-18 2008-11-27 Durect Corporation Improved depot formulations
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
BRPI0811319A2 (pt) 2007-05-25 2015-02-10 Tolmar Therapeutics Inc Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
EP2986278A1 (de) 2013-03-11 2016-02-24 DURECT Corporation Injizierbare zusammensetzung mit gesteuerter freisetzung mit einem hochviskosen flüssigen träger
CN104226191B (zh) * 2014-09-01 2017-04-19 南京理工大学 乙基纤维素多孔颗粒的常温制备方法
EP3784705A4 (de) * 2018-04-23 2022-03-02 Graybug Vision, Inc. Verbesserte kontinuierliche mikropartikelherstellung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
DE69415684T2 (de) * 1993-10-22 1999-06-10 Genentech Inc., San Francisco, Calif. Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe
ATE288270T1 (de) * 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
EP2283821A1 (de) * 1993-11-19 2011-02-16 Alkermes, Inc. Herstellung biodegradierbarer Mikroteilchen, die ein biologisch aktives Mittel enthalten

Also Published As

Publication number Publication date
HK1047539A1 (en) 2003-02-28
HK1047539B (en) 2007-08-24
DE69715191D1 (de) 2002-10-10
TR199802258T2 (en) 2001-11-21
DE69715191T2 (de) 2003-04-30
MY118174A (en) 2004-09-30
HK1016884A1 (en) 1999-11-12
SI0904063T1 (en) 2003-02-28
ATE223206T1 (de) 2002-09-15
EP1210942A2 (de) 2002-06-05
SI1210942T1 (sl) 2007-10-31
ES2183172T3 (es) 2003-03-16
EP1210942A3 (de) 2004-05-26
DE69737515D1 (de) 2007-05-03
DK1210942T3 (da) 2007-07-23
PT1210942E (pt) 2007-06-26
EP1210942B1 (de) 2007-03-21
ATE357218T1 (de) 2007-04-15
DE69737515T2 (de) 2007-12-06
PT904063E (pt) 2003-01-31
DK0904063T3 (da) 2002-12-16
ES2284776T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
SI1210942T1 (sl) Mikrodelci
AU7908098A (en) Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
EP0864326A3 (de) Mehrphasige wirkstoffhaltige Zubereitungsformen
GB2282327B (en) Pesticides, insecticides and insect-repellent compositions containing ethanolamine or derivatives thereof
IL136267A0 (en) 1,3,4-THIADIZOLES AND 1,3,4-OXADIAZOLES AS αVβ3 ANTAGONISTS
PL327108A1 (en) N-([1,2,4]triazole-azinyl)benzene and pyridinsulphonamide compounds and their application as herbicides
DE69414387D1 (de) Objektorientiertes dynamisches "link"-system, welches auf katalogisierte funktionen und klassen zugreift
CA2142126A1 (en) Inhalation powder containing antistatic agent
AU3834095A (en) Particles including degradable material and anti-microbial agent
EP0853883A4 (de) Landwirtschaftliche chemische zusammensetzung mit erhöhter regenfestigkeit
GR3036452T3 (en) Plant-treatment agents
IL114541A0 (en) N-substituted or N,N'-disubstituted-N,N' diacylhydrazines and their use as insecticides
EP0634432A3 (de) Polyurethan-Formmasse und daraus hergestellte, biologisch abbaubare Filamente.
ID17280A (id) Bahan insektisida dan akarisida 1,4-diaril-2-fluoro-2-butena
GB9305120D0 (en) Neuropeptides and their use as insecticides
AU3851799A (en) Lactide-containing polymer and medical material
ZA9610929B (en) Polymeric particulate materials and compositions containing them.
HU9600730D0 (en) 1,4-disubstituted tetrazolinone-derivatives and use thereof as herbicides
AU9019398A (en) Carrier containing soil release polymer and antibacterial agent
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
ATE219042T1 (de) Insektizide und akarizide 1,4-diaryl-2,3-difluor- 2-butene
AU9541898A (en) Azines containing the 5,6-di-hydro-(1,4,2) dioxazine-3-yl group and the use thereof as fungicides
AU2775497A (en) Tooth-cleaning agent in granular form
ZA973563B (en) Ethylene derivatives and pesticides containing said derivatives.
AU4015993A (en) Paving composition, cushion material and horse race track made thereof